Methylene blue retains in vitro activity against early ring-stage artemisinin-resistant Plasmodium falciparum
Malaria Journal · 05.05.2026 · 25 (1)
DOI: 10.1186/s12936-026-05928-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Malaria Journal, online erschienen am 05.05.2026. Verfasst von Olivia Verdier und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shoklo Malaria Research Unit, Faculty of Tropical Medicine, Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Mae Ramat, Thailand. Hauptthemen laut MEDLINE: Methylene Blue, Plasmodium falciparum, Antimalarials, Artemisinins. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Wellcome.
Abstract (Originalsprache)
Artemisinin resistance in Plasmodium falciparum is now well established in three continents and challenges the efficacy of antimalarial drug regimens. This study examined whether methylene blue, an ancient antimalarial drug with a broad spectrum of activity against Plasmodium blood stages, retains its activity against the young rings of artemisinin-resistant parasites. Clinical isolates carrying kelch13 wild type (n = 3), R561H (n = 9), or P441L (n = 10) genotypes were tested with a modified ring survival assay whereby 0- to 3-h post-invasion rings were exposed to a range of methylene blue concentrations. Ring survival was analysed with a Bayesian mixed effects E max model accounting for variability across isolates and experimental replicates. Methylene blue suppressed ring-stage survival at low nanomolar concentrations with no evidence of kelch13 -mediated cross-resistance: the mean 50% inhibitory concentration (IC 50 ) estimates were 23 nM (95% credible interval [CrI]: 15 to 37) for wild type, 27 nM (95% CrI: 21 to 36) for R561H and 14 nM (95% CrI: 10 to 20) for P441L. These findings indicate that methylene blue remains active in vitro against ring-stage artemisinin-resistant parasites.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shoklo Malaria Research Unit, Faculty of Tropical Medicine, Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Mae Ramat, Thailand.
- Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
- Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
- Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
- Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
- Shoklo Malaria Research Unit, Faculty of Tropical Medicine, Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Mae Ramat, Thailand. victor@tropmedres.ac.
Förderung
- Wellcome Trust
- Wellcome
Zitieren
APA
Verdier, O., Christensen, P., Kaewkanya, C., Kobphan, P., Beau, C., Phyo, A. P., Imwong, M., Chotivanich, K., White, N. J., Nosten, F., & Chaumeau, V. (2026). Methylene blue retains in vitro activity against early ring-stage artemisinin-resistant Plasmodium falciparum. Malaria Journal, 25(1). https://doi.org/10.1186/s12936-026-05928-7
Vancouver
Verdier O, Christensen P, Kaewkanya C, Kobphan P, Beau C, Phyo AP, et al. Methylene blue retains in vitro activity against early ring-stage artemisinin-resistant Plasmodium falciparum. Malaria Journal. 2026;25(1). doi:10.1186/s12936-026-05928-7
BibTeX
@article{Verdier2026,
author = {Verdier, Olivia and Christensen, Peter and Kaewkanya, Chalita and Kobphan, Pachinee and Beau, Candy and Phyo, Aung Pyae and Imwong, Mallika and Chotivanich, Kesinee and White, Nicholas J and Nosten, François and Chaumeau, Victor},
title = {Methylene blue retains in vitro activity against early ring-stage artemisinin-resistant Plasmodium falciparum},
journal = {Malaria Journal},
year = {2026},
volume = {25},
number = {1},
doi = {10.1186/s12936-026-05928-7}
}
EUVIMED